The crucial final effector cells responsible for effective immune surveillance are tumor-specific cytotoxic lymphocytes, mostly CD8+ CTLs but also other types of cytotoxic lymphocytes (NK cells, innate lymphoid cells (ILCs), γδ T cells, NKT cells, MAIT cells and CD4+ T cells). The gene discussed is CD4; the disease is neoplasm.